{"nctId":"NCT01165554","briefTitle":"Positron Emission Tomography (PET) Imaging of Brain Amyloid Compared to Post-Mortem Levels","startDateStruct":{"date":"2010-05"},"conditions":["Brain Fibrillarab Levels"],"count":203,"armGroups":[{"label":"[18F] Flutemetamol","type":"EXPERIMENTAL","interventionNames":["Drug: [18F] Flutemetamol"]}],"interventions":[{"name":"[18F] Flutemetamol","otherNames":["AH110690"]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* The subject has a short life expectancy (approximately 1 year or less) as estimated by the Investigator.\n* The subject is 70 years of age or older if cognitively normal, or 55 years of age or older if terminal because of dementia.\n* The subject's general health is adequate to undergo the study procedures.\n\nExclusion Criteria:\n\n* The subject has a contraindication for PET.\n* The subject has a known or suspected hypersensitivity/allergy to \\[18F\\]flutemetamol or to any of the excipients.\n* The subject is unable to tolerate or cooperate with study procedures.","healthyVolunteers":false,"sex":"ALL","minimumAge":"55 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":false},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"The Sensitivity of Blinded Visual Interpretations of [18F]Flutemetamol Positron Emission Tomography (PET) Images Without Anatomic Brain Images for Detecting Brain Fibrillar Amyloid β.","description":"A calculation used to assess Sensitivity was (Number of Blinded Reads determined abnormal by Reader \"N\") divided by the (Total number of abnormal participants).\n\nBlinded visual interpretations of \\[18F\\]flutemetamol Positron Emission Tomography (PET) images without anatomic brain images for detecting brain fibrillar amyloid β.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"81","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"88","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"93","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"93","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"88","spread":null}]}]}]},{"type":"SECONDARY","title":"Blinded Visual Interpretation of Each Subject's Flutemetamol F 18 Injection Brain PET Images as Normal, Without Anatomic Brain Images.","description":"A calculation used to assess Specificity was (Number of Blinded Reads determined normal by Reader \"N\") divided by the (Total number of normal participants).\n\nBlinded visual interpretation of each subject's Flutemetamol F 18 Injection brain PET images as normal, without anatomic brain images.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"88","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"92","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"44","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"80","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"92","spread":null}]}]}]},{"type":"SECONDARY","title":"Blinded Visual Interpretation of Each Subject's Flutemetamol F 18 Injection Brain PET Images as Abnormal, With Anatomic CT Brain Images for Reference.","description":"Blinded visual interpretation of each subject's Flutemetamol F 18 Injection brain PET images as abnormal, with anatomic CT brain images for reference.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"91","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"95","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"98","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"91","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"91","spread":null}]}]}]},{"type":"SECONDARY","title":"Blinded Visual Interpretation of Each Subject's Flutemetamol F 18 Injection Brain PET Images as Normal, With Anatomic CT Brain Images for Reference.","description":"Blinded visual interpretation of each subject's Flutemetamol F 18 Injection brain PET images as normal, with anatomic CT brain images for reference.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"92","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"88","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"56","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"88","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"92","spread":null}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":4,"n":180},"commonTop":[]}}}